You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapse Incidence

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Factors of CMV Reactivation in Patients Receiving of CAR-T Cells

Not yet recruiting
  • Cytomegalovirus Infections
  • +2 more
    • (no location specified)
    Sep 22, 2023

    Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

    Recruiting
    • Leishmaniasis
    • +2 more
      • Lankien, Jonglei, South Sudan
        Lankien Hospital
      Jul 4, 2022

      Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

      Active, not recruiting
      • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
      • Seoul, Korea, Republic of
        Asan Medical Center, University of Ulsan College of Medicine
      Oct 19, 2023

      Day +60 WT1 Assessment on Bone Marrow in Predicting Relapse and

      Completed
      • Assessment of the WT1 Expression Level on Bone Marrow Samples Collected at Day +60 After Allogeneic Stem
        • Roma, Italy
          Servizio E Dh Di Ematologia
        Feb 23, 2023

        Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)

        Active, not recruiting
        • Acute Myeloid Leukemia
        • Myelodysplastic Syndromes
        • Fludarabine, busulfan and melphalan
        • Fludarabine and Busulfan
        • Fuzhou, Fujian, China
        • +8 more
        Aug 14, 2023

        Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

        Not yet recruiting
        • Acute Myeloid Leukemia
        • +4 more
          • (no location specified)
          Nov 1, 2023

          Viral Hepatitis D Relapses Upon Discontinuation of Bulevertide

          Recruiting
          • Chronic Hepatitis D
            • Moscow, Russian Federation
              Center of Target Therapy
            Nov 6, 2023

            Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Atlanta (Fludarabine, Melphalan,

            Completed
            • Chronic Myelogenous Leukemia
            • +9 more
            • Atlanta, Georgia
              Northside Hospital
            Apr 4, 2022

            Acute Myeloid Leukemia in Remission Trial in France (Fludarabine, Busulfan, ATG)

            Not yet recruiting
            • Acute Myeloid Leukemia in Remission
            • Nantes, Loire Atlantique, France
            • +22 more
            Jun 15, 2023

            Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

            Recruiting
            • Hematopoietic Malignancy
            • +2 more
            • Umbilical Cord Blood Transplantation
            • Suzhou, Jiangsu, China
              The First Affiliated Hospital of Soochow university
            Nov 6, 2023

            The Optimization of Haploidentical Hematopoietic Stem Cell

            Not yet recruiting
            • Hematological Malignancy
            • ATG
            • Post-transplantation cyclophosphamide
            • Beijing, Beijing, China
              People's Hospital of Peking University
            Nov 28, 2022

            Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in

            Not yet recruiting
            • Acute Myeloid Leukemia
            • Genetic Predisposition to Disease
            • Collection of blood sample of bone marrow (cohort 1)
            • Collection of blood sample of bone marrow (cohort 2 and 3)
            • (no location specified)
            Mar 6, 2023

            Hematologic Malignancy Trial (Cyclophosphamid, ATG)

            Not yet recruiting
            • Hematologic Malignancy
            • (no location specified)
            Oct 29, 2023

            Digital Droplet PCR in Early Period After Allo-HSCT to Predict

            Completed
            • Measurable Residual Disease
            • Digital Droplet PCR
            • Hangzhou, Zhejiang, China
              The First Hospital of Zhejiang Medical Colleage Zhejiang Univers
            Aug 17, 2023

            Hematologic Tumors Trial in France (Allogeneic (Allo) hematopoietic stem cell transplantation)

            Completed
            • Hematologic Neoplasms
            • Allogeneic (Allo) hematopoietic stem cell transplantation
            • Amiens, France
            • +13 more
            Jan 27, 2023

            Acute Myeloid Leukemia (AML) Trial in Germany

            Recruiting
            • Acute Myeloid Leukemia (AML)
              • Baden-Baden, Baden-Württemberg, Germany
              • +44 more
              Apr 4, 2022

              Myeloid Leukemia, MDS Trial (IFN-?)

              Not yet recruiting
              • Myeloid Leukemia
              • Myelodysplastic Syndromes
              • (no location specified)
              Nov 15, 2023

              Core Binding Factor Acute Myeloid Leukemia (CBF-AML) Trial in Milano (Midostaurin)

              Recruiting
              • Core Binding Factor Acute Myeloid Leukemia (CBF-AML)
              • Milano, Italy
                Ospedale Cà Granda - Niguarda S.C: Ematologia
              Jan 22, 2022

              Allogeneic Disease, GVHD,Acute, Graft Failure Trial (WJ-MSC infusion)

              Not yet recruiting
              • Allogeneic Disease
              • +2 more
              • WJ-MSC infusion
              • (no location specified)
              May 4, 2023

              AML/MDS Trial in Copenhagen (iDLI)

              Recruiting
              • AML/MDS
              • iDLI
              • Copenhagen, Denmark
                Copenhagen University Hospital, Rigshospitalet
              Jan 13, 2023

              Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))

              Recruiting
              • Hematologic Malignancy
              • Myeloid Malignancy
              • Memphis, Tennessee
                St. Jude Children's Research Hospital
              Nov 7, 2022

              Acute Leukemia Trial (Rifaximin with allogeneic stem cell transplant, Allogeneic stem cell transplant)

              Not yet recruiting
              • Acute Leukemia
              • Rifaximin with allogeneic stem cell transplant
              • Allogeneic stem cell transplant
              • (no location specified)
              Sep 21, 2023

              Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome, Diffuse Scleroderma Trial in Shanghai (BRL-301)

              Recruiting
              • Systemic Lupus Erythematosus (SLE)
              • +5 more
              • BRL-301
              • Shanghai, Shanghai, China
                Shanghai ChangZheng hospital
              May 7, 2023

              Acute Leukemia Trial in Tianjin (Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation,

              Recruiting
              • Acute Leukemia
              • Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation
              • haploidentical hematopoietic stem cell transplantation
              • Tianjin, Tianjin, China
                Institute of Hematology & Blood Diseases Hospital, Chinese Acade
              Aug 9, 2022

              AML, Adult, Minimal Residual Disease Trial in Guangzhou (chidamide and azacitidine)

              Not yet recruiting
              • AML, Adult
              • Minimal Residual Disease
              • chidamide and azacitidine
              • Guangzhou, Guangdong, China
                Guangdong Provincial People's Hospital
              Sep 27, 2023